title: A new role for the virtual crossmatch in kidney allograft reuse.
authors.forename: Christopher F
authors.initials: CF
authors.lastname: Bryan
authors.forename: Bashar
authors.initials: B
authors.lastname: Abdulkarim
authors.forename: Jameson
authors.initials: J
authors.lastname: Forster
authors.forename: Paul W
authors.initials: PW
authors.lastname: Nelson
authors.forename: Dennis
authors.initials: D
authors.lastname: Diederich
authors.forename: Daniel
authors.initials: D
authors.lastname: Murillo
authors.forename: Lori
authors.initials: L
authors.lastname: Markham
mesh_terms: D000328:Adult; D005260:Female; D006084:Graft Rejection / Q000276:immunology / Q000517:prevention & control; D006085:Graft Survival; D006680:HLA Antigens / Q000276:immunology*; D006650:Histocompatibility Testing / Q000379:methods*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007518:Isoantibodies / Q000097:blood*; D016030:Kidney Transplantation / Q000009:adverse effects; D016031:Liver Transplantation / Q000009:adverse effects; D008875:Middle Aged; D012086:Reoperation; D014019:Tissue Donors / Q000600:supply & distribution*; D016896:Treatment Outcome
chemical_list: D006680:HLA Antigens; D007166:Immunosuppressive Agents; D007518:Isoantibodies